These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16790162)

  • 21. Hypnosis and Cognitive Behavioral Therapies for the Management of Gastrointestinal Disorders.
    Palsson OS; Ballou S
    Curr Gastroenterol Rep; 2020 Jun; 22(7):31. PubMed ID: 32495233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ["Psychological psychotherapy" in chronic inflammatory intestinal disorders].
    Rüger U
    Z Psychosom Med Psychother; 2007; 53(4):404-7; discussion 408-9. PubMed ID: 18187016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurological and psychiatric aspects of some gastrointestinal diseases].
    Aszalós Z
    Orv Hetil; 2008 Nov; 149(44):2079-86. PubMed ID: 18952527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypnotherapy for treatment of irritable bowel syndrome.
    Webb AN; Kukuruzovic RH; Catto-Smith AG; Sawyer SM
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005110. PubMed ID: 17943840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral medicine approaches to gastrointestinal disorders.
    Whitehead WE
    J Consult Clin Psychol; 1992 Aug; 60(4):605-12. PubMed ID: 1506508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating psychosocial approaches into the management of childhood functional gastrointestinal disorders: a role for social work.
    Heinsch M; Nightingale S
    Soc Work Health Care; 2019; 58(5):431-443. PubMed ID: 30836048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceptions of gastroenterologists and patients regarding irritable bowel syndrome and inflammatory bowel disease.
    Levy S; Segev M; Reicher-Atir R; Steinmetz A; Horev N; Niv Y; Dickman R
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):40-6. PubMed ID: 24025978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motivation for psychotherapy in patients with functional gastrointestinal disorders.
    Martens U; Enck P; Matheis A; Herzog W; Klosterhalfen S; Rühl A; Zipfel S; Sammet I
    Psychosomatics; 2010; 51(3):225-9. PubMed ID: 20484720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychosomatic approach for IBS patients].
    Handa M; Tsubaki H; Kubo C
    Nihon Rinsho; 2006 Aug; 64(8):1505-8. PubMed ID: 16898622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Psychosomatic dermatology].
    Gieler U; Niemeier V; Kupfer J; Harth W
    Hautarzt; 2008 May; 59(5):415-32; quiz 433. PubMed ID: 18777640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social learning, affective state and passive coping in irritable bowel syndrome and inflammatory bowel disease.
    Crane C; Martin M
    Gen Hosp Psychiatry; 2004; 26(1):50-8. PubMed ID: 14757303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experiences of patients with chronic gastrointestinal conditions: in their own words.
    McCormick JB; Hammer RR; Farrell RM; Geller G; James KM; Loftus EV; Mercer MB; Tilburt JC; Sharp RR
    Health Qual Life Outcomes; 2012 Mar; 10():25. PubMed ID: 22401607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD).
    Gostoli S; Ferrara F; Quintavalle L; Tommasino S; Gigante G; Montecchiarini M; Urgese A; Guolo F; Subach R; D'Oronzo A; Polifemo A; Buonfiglioli F; Cennamo V; Rafanelli C
    BMC Psychol; 2024 Apr; 12(1):211. PubMed ID: 38632660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the Empirical Evidence.
    Palsson OS
    Am J Clin Hypn; 2015 Oct; 58(2):134-58. PubMed ID: 26264539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review: psychosocial factors associated with pain in inflammatory bowel disease.
    Sweeney L; Moss-Morris R; Czuber-Dochan W; Meade L; Chumbley G; Norton C
    Aliment Pharmacol Ther; 2018 Mar; 47(6):715-729. PubMed ID: 29359343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders.
    Chang L; Toner BB; Fukudo S; Guthrie E; Locke GR; Norton NJ; Sperber AD
    Gastroenterology; 2006 Apr; 130(5):1435-46. PubMed ID: 16678557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?
    Pinn DM; Aroniadis OC; Brandt LJ
    Neurogastroenterol Motil; 2015 Jan; 27(1):19-29. PubMed ID: 25424663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric inflammatory bowel disease and depression: treatment implications.
    Keethy D; Mrakotsky C; Szigethy E
    Curr Opin Pediatr; 2014 Oct; 26(5):561-7. PubMed ID: 25010217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Psychophysiology of visceral pain syndromes].
    Häuser W; Grandt D
    Schmerz; 2002 Dec; 16(6):460-6. PubMed ID: 12474032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of inflammatory bowel disease on health care utilization and quality of life.
    Nurmi E; Haapamäki J; Paavilainen E; Rantanen A; Hillilä M; Arkkila P
    Scand J Gastroenterol; 2013 Jan; 48(1):51-7. PubMed ID: 22577851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.